High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 1001-1004

  Malaty, H ^a   El Zimaity, H M T ^a   Genta, R M ^a   Cole, R A ^a   Graham, D Y ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

EID: 0029849480     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.77248000.x     Document Type: Article

References (18)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. J Am Med Assoc 1994; 272: 65-9.
2. Borsch GM, Graham DY. Helicobacter pylori. In: Collen MJ, Benjamin SB, eds. Pharmacology of Peptic Ulcer Disease. Handbook of Experimental Pharmacology, Vol 99. Berlin: Springer, 1991: 107-48.
3. Tytgat GN, Noach LA, Rauws EA. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993; 22: 127-39.
4. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76-89.
5. Graham DY. Determinants of antimicrobial effectiveness in H. pylori gastritis. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure. Dordrecht: Kluwer Academic, 1994: 531-7.
6. van der Hulst RWM, Keller JJ, Rauws EA, Tytgat GNJ. Treatment of Helicobacter pylori infection in Humans: a review of the world literature. Helicobacter 1996; 1: 6-19.
7. Graham KS, Malaty H, El-Zimaity HM, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90: 1415-8.
8. Al-Assi MT, Cole RA, Karttunen TJ, et al. Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. Am J Gastroenterol 1995; 90: 1411-4.
9. Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 337: 1486 (Letter).
10. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490-6.
11. Suerbaum S, Laying H, Klemm K, Opferkuch W. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10: 92-3 (Letter.)
12. Sherman P, Shames B, Loo V, et al. Omeprazole therapy for Helicobacter pylori infection. Scand J Gastroenterol 1992; 27: 1018-22.
13. Hunt RH. pH and Hp - gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism. Am J Gastroenterol 1993; 88: 481-3.
14. Bayerdörffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-7.
15. Miehlke S, Mannes GA, Lehn N, et al. An increasing dose of omeprazole combined with amoxicillin improves the cure of Helicobacter pylori infection. Gastroenterology 1995; 108: A167 (Abstract).
16. 2 blocker maintenance therapy after peptic ulcer bleeding - a prospective randomized trial. Gastroenterology 1995; 108: A156 (Abstract).
17. Bayerdörffer E, Miehlke S, Mannes GA. Helicobacter pylori eradication therapy with omeprazole and amoxicillin: current status. Leber Magen Darm 1994; 24: 228-32.
18. Bayerdörffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697-702.